Downloads: 6 | Views: 289 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Biochemistry | India | Volume 11 Issue 3, March 2022 | Popularity: 5.6 / 10
A Study of D-Dimer Levels with and without Co-Morbidities as a Prognostic Marker for Disease Severity in COVID-19 Patients
Dr. Falak Fatima, Dr. Sujatha Rani
Abstract: Background: A novel coronavirus COVID-19 pandemic called SARS-CoV-2 is defining global health crisis of our time and has resulted in the outbreak of respiratory illness. Coagulation system is active in critically ill patients and D-dimer levels co-relate with activation of pro-inflammatory cytokine cascade. As COVID-19 is caused by severe respiratory syndrome coronavirus 2, increased D-dimer were reported in corona like infections due to activation of Coagulation by respiratory viruses. Elevated D-dimer following anticoagulation for thrombotic event indicates increased risk of recurrent thrombosis. Objectives: To assess the levels of D-Dimer in COVID-19 patients with and without co-morbidities. Methodology: This is an observational study done for about 40 confirmed cases of COVID-19 in the month of August 2020to September 2020. D-dimer values were determined in an age groups 30-60years including male and female patients with and without co-morbidities like Diabetes, Hypertension. Results: In my study population of 40 patients ? 50%i. e., 20 patients were with co-morbidities and 50% i. e., 20 patients were without co-morbidities. Among patients with co-morbidities, D-dimer levels observed were <500 ng/ml in about 5%, 500-1000 ng/ml in 55%, and >1000 ng/ml in 40% when compared with that of patients without co-morbidities, D-dimer levels observed were <500 ng/ml in 90%, 500-1000 ng/ml in 10% and >1000 ng/ml in 0%. p value is estimated as (p=0.007) which is statistically significant. Conclusion: We have come to conclusion that D-dimer levels were markedly elevated in COVID-19 patients with co-morbidities when compared with that of COVID-19 patients without co-morbidities.
Keywords: COVID-19, SARS-COV-2, Severe Respiratory Syndrome Coronavirus-2, Comorbidities, Diabetes, Hypertension, Cytokine Cascade
Edition: Volume 11 Issue 3, March 2022
Pages: 753 - 755
DOI: https://www.doi.org/10.21275/SR22314171908
Make Sure to Disable the Pop-Up Blocker of Web Browser
Similar Articles
Downloads: 3 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Comparative Studies, Biochemistry, India, Volume 10 Issue 6, June 2021
Pages: 264 - 268Estimation of Glomerular Filtration Rate by using Two Different Methods for Creatinine Estimation in Chronic Kidney Disease: Comparative Study
Shipra Shrivastava
Downloads: 81 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper, Biochemistry, India, Volume 9 Issue 11, November 2020
Pages: 176 - 182A Comparative Study of Serum Lipids and Lipoprotein - A Levels of Women with Pregnancy Induced Hypertension (PIH) and Normal Pregnant Women
Syeda Ayesha Fatima, Madhavi Latha, N. Vani
Downloads: 121
Review Papers, Biochemistry, India, Volume 9 Issue 4, April 2020
Pages: 1570 - 1572Dominance in the Narrative Coronavirus (COVID-19) Infection: A Review Article
Sirisha Nagala, Raghava Rao Tamanam, Kumar Ganesh
Downloads: 185 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper, Biochemistry, India, Volume 8 Issue 10, October 2019
Pages: 1543 - 1545A Phytochemical Screening of the Ethanolic Extract of Aloe Vera Gel
Abhishek Jha, Deena Prakash, Divya Bisht
Downloads: 268 | Weekly Hits: ⮙1 | Monthly Hits: ⮙3
Review Papers, Biochemistry, India, Volume 12 Issue 1, January 2023
Pages: 1 - 2Study of LDH and Uric Acid Levels in Pre Eclapmsia Women
Harsha .V, Dr. Prajna P Shetty, Nishana .T